Shanghai MicroPort EP MedTech Completed the First Multi-electrode Ablation Case in the Clinical Trial of FlashPoint™ Renal Artery RF Ablation System
On 27 December 2013, Shanghai MicroPort EP MedTech Co., Ltd., a subsidiary of MicroPort Group, completed the first multi-electrode ablation case in the clinical trial of FlashPoint™ Renal Artery RF Ablation System. The case was performed in the Second Affiliated Hospital of Chongqing Medical University. The procedure was performed by the Professor Yuehui Yin from the Department of Cardiology in the hospital.
In recent years, percutaneous renal artery catheter RF ablation has received a lot of attention in the industry. The clinical trial is designed to evaluate the safety and efficacy of FlashPoint™ renal artery catheter RF ablation system for the treatment of resistant hypertension.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.